Patent · US Active

Cytokine conjugates for the treatment of proliferative and infectious diseases

US11701407B2 · kind B2 · utility

4Cited by

230References

28Claims

0Family size

Assignee

SYNTHORX, INC. · US

Inventors

Jerod PTACIN · Beloit, US
Carolina E. CAFFARO · San Diego, US
Marcos MILLA · Carlsbad, US

Key dates

Filing date	Feb 27, 2020
Grant date	Jul 18, 2023
Priority date	—
Expiry date	Apr 25, 2040

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Disclosed herein are interleukin (IL) conjugates (e.g., IL-2 conjugates) and use in the treatment of one or more indications. Also described herein are pharmaceutical compositions and kits comprising one or more of the interleukin conjugates (e.g., IL-2 conjugates).

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.